首页 > 最新文献
paperpass

Gaceta sanitaria最新文献

英文 中文
Cost-effectiveness of direct oral anticoagulants in non-valvular atrial fibrillation. 直接口服抗凝剂治疗非瓣膜性房颤的成本-效果。
IF 1.5 Pub Date : 2025-01-01 Epub Date: 2025-02-18 DOI: 10.1016/j.gaceta.2025.102451
Inigo Gorostiza, Amaia Bilbao-Gonzalez, Javier Mar

Objective: There is evidence on the efficiency of new direct oral anticoagulants (DOAC), mostly based on experimental efficacy data, but there is also a need to assess their cost-effectiveness in routine clinical practice using patient-level data. We designed a retrospective cohort study to assess the cost-effectiveness of DOAC compared to acenocoumarol in patients with non-valvular atrial fibrillation (NVAF) with a follow-up of up to 7 years.

Method: Basque Health Service-registered patients who started oral anticoagulant treatment between 2013 and 2016 were included in the study and followed up until the end of 2019. Data were extracted from an electronic medical record management system. Effectiveness was expressed in terms of life years gained and adjusted for health-related quality of life (i.e., quality-adjusted life years [QALY]). Propensity score techniques were used to adjust the estimates for differences between groups in baseline characteristics.

Results: A total of 10,843 new users of oral anticoagulants with a mean follow-up of 4.1 years were included. The incremental cost-effectiveness ratio of DOAC compared to acenocoumarol ranged from €1,732 to €2,556/QALY, while the incremental net benefit for different willingness-to-pay thresholds was only negative for values below €3,000/QALY.

Conclusions: Based on the analysis of data from clinical practice and the similarity of results using several different techniques to adjust for bias associated with observational studies, we conclude that DOAC would be an efficient alternative for the treatment of patients with NVAF.

目的:新的直接口服抗凝剂(DOAC)的有效性有证据,主要基于实验疗效数据,但也需要在常规临床实践中使用患者水平的数据来评估其成本效益。我们设计了一项回顾性队列研究,通过长达7年的随访来评估DOAC与阿塞诺库马洛在非瓣膜性心房颤动(NVAF)患者中的成本-效果。方法:将2013年至2016年在巴斯克卫生服务中心注册并开始口服抗凝治疗的患者纳入研究,随访至2019年底。数据从电子病历管理系统中提取。有效性以获得的生命年表示,并根据与健康相关的生活质量进行调整(即质量调整生命年[QALY])。倾向评分技术用于调整各组之间基线特征差异的估计。结果:共纳入10843例口服抗凝剂新使用者,平均随访4.1年。DOAC与阿萨诺古玛罗的增量成本效益比在1732欧元至2556欧元/质量aly之间,而不同支付意愿阈值的增量净效益仅在低于3000欧元/质量aly时为负。结论:基于对临床实践数据的分析,以及使用几种不同技术来调整与观察性研究相关的偏倚的结果的相似性,我们得出结论,DOAC将是治疗非瓣瓣性房颤患者的有效替代方案。
{"title":"Cost-effectiveness of direct oral anticoagulants in non-valvular atrial fibrillation.","authors":"Inigo Gorostiza, Amaia Bilbao-Gonzalez, Javier Mar","doi":"10.1016/j.gaceta.2025.102451","DOIUrl":"10.1016/j.gaceta.2025.102451","url":null,"abstract":"<p><strong>Objective: </strong>There is evidence on the efficiency of new direct oral anticoagulants (DOAC), mostly based on experimental efficacy data, but there is also a need to assess their cost-effectiveness in routine clinical practice using patient-level data. We designed a retrospective cohort study to assess the cost-effectiveness of DOAC compared to acenocoumarol in patients with non-valvular atrial fibrillation (NVAF) with a follow-up of up to 7 years.</p><p><strong>Method: </strong>Basque Health Service-registered patients who started oral anticoagulant treatment between 2013 and 2016 were included in the study and followed up until the end of 2019. Data were extracted from an electronic medical record management system. Effectiveness was expressed in terms of life years gained and adjusted for health-related quality of life (i.e., quality-adjusted life years [QALY]). Propensity score techniques were used to adjust the estimates for differences between groups in baseline characteristics.</p><p><strong>Results: </strong>A total of 10,843 new users of oral anticoagulants with a mean follow-up of 4.1 years were included. The incremental cost-effectiveness ratio of DOAC compared to acenocoumarol ranged from €1,732 to €2,556/QALY, while the incremental net benefit for different willingness-to-pay thresholds was only negative for values below €3,000/QALY.</p><p><strong>Conclusions: </strong>Based on the analysis of data from clinical practice and the similarity of results using several different techniques to adjust for bias associated with observational studies, we conclude that DOAC would be an efficient alternative for the treatment of patients with NVAF.</p>","PeriodicalId":94017,"journal":{"name":"Gaceta sanitaria","volume":" ","pages":"102451"},"PeriodicalIF":1.5,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143461157","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Allocating socioeconomic census data to primary care areas: an improvement in small-area analyses. 将社会经济普查数据分配到初级保健地区:小区域分析的改进。
IF 1.5 Pub Date : 2025-01-01 Epub Date: 2025-03-14 DOI: 10.1016/j.gaceta.2025.102464
Francisco Estupiñán-Romero, Santiago Royo-Sierra, Javier González-Galindo, Manuel Ridao-López, Enrique Bernal-Delgado

Objective: Provide a method for reusing National Institute of Statistics (INE) socioeconomic data and reconstructing the Spanish National Health System primary care areas (PCA) from INE census tracts.

Method: The reconstruction of PCA boundaries entailed aligning, assigning, and integrating census tracts within the limits of the PCA using 2022 INE and 2018 Atlas VPM digital maps.

Results: 36,282 census tracts were assigned to 2,405 PCA. The alignment of digital maps showed a programmatic assignment of 99.7% of the census tracts within PCA; just ten census tracts must be manually assigned. The net average income per capita distribution from INE was consistent along the newly reconstructed PCA.

Conclusions: We have proposed a reliable solution to integrate socioeconomic data from INE census statistics into PCA, enhancing data researchers' capacities in joint analyses of socioeconomic determinants and healthcare.

目的:为重新利用国家统计局(INE)的社会经济数据和重建西班牙国家卫生系统初级保健区(PCA)提供一种方法。方法:PCA边界的重建包括使用2022年INE和2018年Atlas VPM数字地图在PCA范围内对齐、分配和整合人口普查区。结果:36282个人口普查区分配给2405个PCA。数字地图的对齐显示了PCA内99.7%的人口普查区的规划分配;只有10个人口普查区必须手工分配。净平均人均收入分布沿新重建的主成分分析是一致的。结论:我们提出了一个可靠的解决方案,将来自INE人口普查统计的社会经济数据整合到PCA中,提高了数据研究人员联合分析社会经济决定因素和医疗保健的能力。
{"title":"Allocating socioeconomic census data to primary care areas: an improvement in small-area analyses.","authors":"Francisco Estupiñán-Romero, Santiago Royo-Sierra, Javier González-Galindo, Manuel Ridao-López, Enrique Bernal-Delgado","doi":"10.1016/j.gaceta.2025.102464","DOIUrl":"10.1016/j.gaceta.2025.102464","url":null,"abstract":"<p><strong>Objective: </strong>Provide a method for reusing National Institute of Statistics (INE) socioeconomic data and reconstructing the Spanish National Health System primary care areas (PCA) from INE census tracts.</p><p><strong>Method: </strong>The reconstruction of PCA boundaries entailed aligning, assigning, and integrating census tracts within the limits of the PCA using 2022 INE and 2018 Atlas VPM digital maps.</p><p><strong>Results: </strong>36,282 census tracts were assigned to 2,405 PCA. The alignment of digital maps showed a programmatic assignment of 99.7% of the census tracts within PCA; just ten census tracts must be manually assigned. The net average income per capita distribution from INE was consistent along the newly reconstructed PCA.</p><p><strong>Conclusions: </strong>We have proposed a reliable solution to integrate socioeconomic data from INE census statistics into PCA, enhancing data researchers' capacities in joint analyses of socioeconomic determinants and healthcare.</p>","PeriodicalId":94017,"journal":{"name":"Gaceta sanitaria","volume":" ","pages":"102464"},"PeriodicalIF":1.5,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143634229","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Differential seasonality in surgical waiting list discharges in Spain: implications for management]. [西班牙手术候诊患者的季节性差异:对管理的影响]。
IF 1.5 Pub Date : 2025-01-01 Epub Date: 2025-05-20 DOI: 10.1016/j.gaceta.2025.102499
Jaime Pinilla, Francisco José Estupiñán-Romero, Beatriz González López-Valcárcel, Manuel Ridao-López, Enrique Bernal-Delgado

Objective: To analyse the seasonal variability of surgical procedures with guaranteed maximum waiting times with a view to figure out whether there are differences between urgent admissions and need-sensitive procedures, and those supply-sensitive.

Method: Retrospective longitudinal observational study with administrative data on hospital episodes of the National Health System for 14 autonomous communities, years 2003 to 2022, aggregated monthly. The elective supply-sensitive surgical procedures with guaranteed times were selected. Then, as to conduct, the comparative analyses, we selected need-sensitive elective procedures for aortic-coronary bypass surgery in patients over 40 years of age, percutaneous transluminal coronary angioplasty in patients over 40 years of age, and breast cancer surgery in adult women up to 85 years of age to compare differences in seasonal variability. Finally, in order to get a basal level of seasonal variation we used emergency admissions for hip fracture in patients over 65 years of age and admission for acute myocardial infarction in patients over 40 years of age. A multiplicative decomposition of the series was applied to calculate the seasonal rate of change, and a placebo test was applied to test the seasonal variability of health care delivery across comparison groups.

Results: Supply-sensitive elective surgery showed a marked seasonal variability, with rates of variation above 1.20 in months such as February, March, May and June, and very low values in the summer months, 0.42 in August. The placebo test confirmed significant differences with respect to the expected distribution according to working days. In contrast, in those need-sensitive procedures and emergency admissions, the seasonal variability was found to be almost non-existent.

Conclusions: A reasonable management objective for hospitals could be to reduce the monthly variability in elective supply-sensitive surgical activity through improving indication, re-organizing of human resources and incentives to reduce activity.

目的:分析保证最长等待时间的外科手术的季节性变化,以了解紧急入院和需求敏感的手术与供应敏感的手术之间是否存在差异。方法:对2003 ~ 2022年全国14个自治区卫生系统住院事件管理资料进行回顾性纵向观察研究。选择供给量敏感且保证手术时间的选择性手术。然后,为了进行比较分析,我们选择了40岁以上患者的主动脉-冠状动脉搭桥手术、40岁以上患者的经皮腔内冠状动脉成形术和85岁以下成年女性乳腺癌手术的需求敏感选择性手术,以比较季节变异性的差异。最后,为了获得季节变化的基本水平,我们使用了65岁以上患者髋部骨折的急诊入院和40岁以上患者急性心肌梗死的入院。采用系列的乘法分解来计算季节性变化率,并采用安慰剂检验来测试各组间卫生保健服务的季节性变异性。结果:供应敏感型择期手术具有明显的季节变异性,2、3、5、6月份变化率均在1.20以上,夏季变化率极低,8月份为0.42。安慰剂检验证实了根据工作日的预期分布存在显著差异。相比之下,在那些对需求敏感的程序和紧急入院中,发现季节变化几乎不存在。结论:医院合理的管理目标是通过改善指征、重组人力资源和激励措施来减少选择性供应敏感手术活动的月度变化。
{"title":"[Differential seasonality in surgical waiting list discharges in Spain: implications for management].","authors":"Jaime Pinilla, Francisco José Estupiñán-Romero, Beatriz González López-Valcárcel, Manuel Ridao-López, Enrique Bernal-Delgado","doi":"10.1016/j.gaceta.2025.102499","DOIUrl":"10.1016/j.gaceta.2025.102499","url":null,"abstract":"<p><strong>Objective: </strong>To analyse the seasonal variability of surgical procedures with guaranteed maximum waiting times with a view to figure out whether there are differences between urgent admissions and need-sensitive procedures, and those supply-sensitive.</p><p><strong>Method: </strong>Retrospective longitudinal observational study with administrative data on hospital episodes of the National Health System for 14 autonomous communities, years 2003 to 2022, aggregated monthly. The elective supply-sensitive surgical procedures with guaranteed times were selected. Then, as to conduct, the comparative analyses, we selected need-sensitive elective procedures for aortic-coronary bypass surgery in patients over 40 years of age, percutaneous transluminal coronary angioplasty in patients over 40 years of age, and breast cancer surgery in adult women up to 85 years of age to compare differences in seasonal variability. Finally, in order to get a basal level of seasonal variation we used emergency admissions for hip fracture in patients over 65 years of age and admission for acute myocardial infarction in patients over 40 years of age. A multiplicative decomposition of the series was applied to calculate the seasonal rate of change, and a placebo test was applied to test the seasonal variability of health care delivery across comparison groups.</p><p><strong>Results: </strong>Supply-sensitive elective surgery showed a marked seasonal variability, with rates of variation above 1.20 in months such as February, March, May and June, and very low values in the summer months, 0.42 in August. The placebo test confirmed significant differences with respect to the expected distribution according to working days. In contrast, in those need-sensitive procedures and emergency admissions, the seasonal variability was found to be almost non-existent.</p><p><strong>Conclusions: </strong>A reasonable management objective for hospitals could be to reduce the monthly variability in elective supply-sensitive surgical activity through improving indication, re-organizing of human resources and incentives to reduce activity.</p>","PeriodicalId":94017,"journal":{"name":"Gaceta sanitaria","volume":" ","pages":"102499"},"PeriodicalIF":1.5,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144121818","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pricing and reimbursement of off-patent medicines dispensed in community pharmacies. 社区药房非专利药品的定价和报销。
IF 1.5 Pub Date : 2025-01-01 Epub Date: 2025-07-09 DOI: 10.1016/j.gaceta.2025.102506
David Epstein

Objective: After expiry of the patent, price competition can lead to savings. However, in Spain, competition in the retail price of prescription off-patent medicines in pharmacies is rare, while large discounts are negotiated in the wholesale market. Some countries have moved from "competition by discount" to "competition by price". This article compares retail prices in Spain with other countries, and the factors that promote price competition.

Method: This article reviews the literature comparing prices and the factors influencing competition. A detailed analysis of the design of the market was conducted for Spain and Sweden. Interviews were conducted with experts. The systems were compared for the definition of exchange groups, prescription and substitution, how retail prices and profit margins are regulated, and safeguards to avoid risk of shortages.

Results: Depending on sample and methodology, prices in Spain may be on average 51% to 109% greater than Sweden. Broadly, the literature recommends that the off-patent market should be regulated by competitive forces rather than price caps. Spain and Sweden have many features in common. Key differences are: 1) Sweden allows price differences between medicines, and for prices to rise as well as fall, 2) the tendering process, 3) patient choice, and 4) the architecture of the exchange groups CONCLUSIONS: In Spain, first generic or biosimilar entry provokes a 25-40% discount, but thereafter prices are static. In Sweden, price competition is dynamic. This includes, within limits, freedom to set prices, product differentiation, and patient choice.

目的:专利期满后,价格竞争可以节约成本。然而,在西班牙,药店处方非专利药品的零售价格竞争很少,而批发市场上的大幅折扣是通过谈判达成的。一些国家已经从“折扣竞争”转向“价格竞争”。本文比较了西班牙与其他国家的零售价格,以及促进价格竞争的因素。方法:查阅文献,比较价格和竞争影响因素。对西班牙和瑞典的市场设计进行了详细分析。对专家进行了采访。对这两种制度进行了比较,包括对交换集团的定义、处方和替代、如何监管零售价格和利润率,以及避免短缺风险的保障措施。结果:根据样本和方法的不同,西班牙的价格可能比瑞典平均高出51%至109%。总的来说,文献建议非专利市场应该由竞争力量而不是价格上限来调节。西班牙和瑞典有许多共同之处。关键的区别在于:1)瑞典允许药品之间的价格差异,并允许价格上涨或下跌;2)招标过程;3)患者选择;4)交换组的结构。结论:在西班牙,首次仿制药或生物仿制药进入可获得25-40%的折扣,但此后价格是不变的。在瑞典,价格竞争是动态的。在一定范围内,这包括定价、产品差异化和患者选择的自由。
{"title":"Pricing and reimbursement of off-patent medicines dispensed in community pharmacies.","authors":"David Epstein","doi":"10.1016/j.gaceta.2025.102506","DOIUrl":"10.1016/j.gaceta.2025.102506","url":null,"abstract":"<p><strong>Objective: </strong>After expiry of the patent, price competition can lead to savings. However, in Spain, competition in the retail price of prescription off-patent medicines in pharmacies is rare, while large discounts are negotiated in the wholesale market. Some countries have moved from \"competition by discount\" to \"competition by price\". This article compares retail prices in Spain with other countries, and the factors that promote price competition.</p><p><strong>Method: </strong>This article reviews the literature comparing prices and the factors influencing competition. A detailed analysis of the design of the market was conducted for Spain and Sweden. Interviews were conducted with experts. The systems were compared for the definition of exchange groups, prescription and substitution, how retail prices and profit margins are regulated, and safeguards to avoid risk of shortages.</p><p><strong>Results: </strong>Depending on sample and methodology, prices in Spain may be on average 51% to 109% greater than Sweden. Broadly, the literature recommends that the off-patent market should be regulated by competitive forces rather than price caps. Spain and Sweden have many features in common. Key differences are: 1) Sweden allows price differences between medicines, and for prices to rise as well as fall, 2) the tendering process, 3) patient choice, and 4) the architecture of the exchange groups CONCLUSIONS: In Spain, first generic or biosimilar entry provokes a 25-40% discount, but thereafter prices are static. In Sweden, price competition is dynamic. This includes, within limits, freedom to set prices, product differentiation, and patient choice.</p>","PeriodicalId":94017,"journal":{"name":"Gaceta sanitaria","volume":" ","pages":"102506"},"PeriodicalIF":1.5,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144610712","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Resource use and healthcare costs in long-term breast cancer survivors (CONCEPT-COSTS)]. [长期乳腺癌幸存者的资源使用和医疗费用(CONCEPT-COSTS)]。
IF 1.5 Pub Date : 2025-01-01 Epub Date: 2025-06-18 DOI: 10.1016/j.gaceta.2025.102507
Cristina Valcárcel Nazco, Benjamín Rodríguez Díaz, David Abbad Gómez, Carmen Guirado Fuentes, Francisco Estupiñán Romero, Enrique Bernal Delgado, María Sala Serra

Objective: To analyze the use of resources and healthcare costs of a cohort of long-term survivors of breast cancer in four autonomous communities in Spain (Aragon, Catalonia, Madrid and Navarre) by assessing their pathways in the National Health System.

Method: Patient pathways were analyzed based on their interactions with the National Health System between 2012 and 2016. Healthcare pathways were obtained from the CONCEPT project and were use to examine resource use, associated costs, and to analyze potential differences between cohorts and regions. A total of 18,527 women were included, of whom 6115 were long-term survivors of breast cancer and 12,412 formed the control group, consisting of women with no history of the disease, matched by age and healthcare area with the survivors. Regression models were applied to analyze factors associated with the cost of trajectories.

Results: Long-term survivors of breast cancer had a higher use of healthcare resources, and a higher number of comorbidity and drug use compared to the control group, with statistically significant differences. Costs were also higher for survivors, especially in outpatient clinics. Factors such as the number of drugs, comorbidity and the Charlson index were identified as the main factors associated with higher healthcare costs in both groups.

Conclusions: This study identified the costs of healthcare pathways in long-term breast cancer survivors and suggests that the methodology used could help healthcare professionals allocate resources more efficiently.

目的:通过评估西班牙四个自治区(阿拉贡、加泰罗尼亚、马德里和纳瓦拉)的乳腺癌长期幸存者在国家卫生系统中的途径,分析其资源使用和医疗费用。方法:分析2012 - 2016年患者与国家卫生系统互动的路径。从CONCEPT项目中获得了医疗保健途径,用于检查资源使用、相关成本,并分析队列和地区之间的潜在差异。总共包括18,527名妇女,其中6115名是乳腺癌的长期幸存者,12,412名组成对照组,由没有疾病史的妇女组成,按年龄和保健地区与幸存者相匹配。采用回归模型分析与轨迹成本相关的因素。结果:与对照组相比,乳腺癌长期幸存者的医疗资源使用、合并症和药物使用数量均较高,差异有统计学意义。幸存者的费用也更高,尤其是在门诊。药物数量、合并症和Charlson指数等因素被确定为与两组较高的医疗费用相关的主要因素。结论:本研究确定了长期乳腺癌幸存者的医疗保健途径的成本,并建议使用的方法可以帮助医疗保健专业人员更有效地分配资源。
{"title":"[Resource use and healthcare costs in long-term breast cancer survivors (CONCEPT-COSTS)].","authors":"Cristina Valcárcel Nazco, Benjamín Rodríguez Díaz, David Abbad Gómez, Carmen Guirado Fuentes, Francisco Estupiñán Romero, Enrique Bernal Delgado, María Sala Serra","doi":"10.1016/j.gaceta.2025.102507","DOIUrl":"10.1016/j.gaceta.2025.102507","url":null,"abstract":"<p><strong>Objective: </strong>To analyze the use of resources and healthcare costs of a cohort of long-term survivors of breast cancer in four autonomous communities in Spain (Aragon, Catalonia, Madrid and Navarre) by assessing their pathways in the National Health System.</p><p><strong>Method: </strong>Patient pathways were analyzed based on their interactions with the National Health System between 2012 and 2016. Healthcare pathways were obtained from the CONCEPT project and were use to examine resource use, associated costs, and to analyze potential differences between cohorts and regions. A total of 18,527 women were included, of whom 6115 were long-term survivors of breast cancer and 12,412 formed the control group, consisting of women with no history of the disease, matched by age and healthcare area with the survivors. Regression models were applied to analyze factors associated with the cost of trajectories.</p><p><strong>Results: </strong>Long-term survivors of breast cancer had a higher use of healthcare resources, and a higher number of comorbidity and drug use compared to the control group, with statistically significant differences. Costs were also higher for survivors, especially in outpatient clinics. Factors such as the number of drugs, comorbidity and the Charlson index were identified as the main factors associated with higher healthcare costs in both groups.</p><p><strong>Conclusions: </strong>This study identified the costs of healthcare pathways in long-term breast cancer survivors and suggests that the methodology used could help healthcare professionals allocate resources more efficiently.</p>","PeriodicalId":94017,"journal":{"name":"Gaceta sanitaria","volume":" ","pages":"102507"},"PeriodicalIF":1.5,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144334733","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Loneliness as a determinant of health: evidence from the Health Survey of Catalonia. 孤独是健康的决定因素:来自加泰罗尼亚健康调查的证据。
IF 1.5 Pub Date : 2025-01-01 Epub Date: 2025-06-20 DOI: 10.1016/j.gaceta.2025.102491
Helena M Hernández-Pizarro, Albert Prades-Colomé, Guillem López-Casasnovas

Objective: This study investigates the health effects of loneliness among adults (18+ years) and elderly adults (60+ years).

Method: Using data from the Health Survey of Catalonia (ESCA), 2013-2019, the effects of loneliness on health and healthcare utilization outcomes are estimated. Ordinary least squares estimates are provided to explore the channels affecting such relationships.

Results: Loneliness is significantly associated to worse health outcomes in all age groups. Among adults, it reduces self-perceived health by 7.1%, increases multi-morbidities by 22.1%, and raises the probability of depression and anxiety by 65.8%. Consequently, a positive and strong association between suffering from loneliness and the use of healthcare resources is documented: with a 7.4% rise in medication use, 20.9% more emergency care visits, and 6.1% higher primary care use. Results for the elderly are aligned with adults, although the magnitude associated to self-perceived health is substantially greater (13.2%). Channels exploration identifies living alone (with a 97.3% increase) and poor household habitability (33.5% increase) as key predictors in all the analysis. Being foreign (60.3% increase in the adult population and 106% in the elderly population) and gender (women, 26.8% for the adult population and 27.5% in the elderly population) become relevant factors explaining loneliness.

Conclusions: This study documents the impact of loneliness in Catalonia. Loneliness is associated to significant worse health and more use of healthcare. Tackling individuals with higher risk factors for loneliness could help preventing its concerning consequences on health and healthcare system.

目的:探讨成人(18岁以上)和老年人(60岁以上)孤独感对健康的影响。方法:利用2013-2019年加泰罗尼亚健康调查(ESCA)的数据,估计孤独感对健康和医疗保健利用结果的影响。提供了普通最小二乘估计来探索影响这种关系的渠道。结果:在所有年龄组中,孤独感与较差的健康结果显著相关。在成年人中,它使自我感觉健康下降7.1%,使多种疾病发病率增加22.1%,使抑郁和焦虑的可能性增加65.8%。因此,孤独感与医疗保健资源的使用之间存在着积极而强烈的联系:药物使用增加了7.4%,急诊就诊增加了20.9%,初级保健使用增加了6.1%。老年人的结果与成年人一致,尽管与自我感知健康相关的幅度要大得多(13.2%)。渠道探索发现,独居(增加97.3%)和家庭宜居性差(增加33.5%)是所有分析中的关键预测因素。外国人(成年人口增加60.3%,老年人口增加106%)和性别(女性,成年人口增加26.8%,老年人口增加27.5%)成为解释孤独的相关因素。结论:本研究记录了加泰罗尼亚孤独感的影响。孤独与健康状况明显恶化和更多地使用医疗保健有关。解决具有较高孤独风险因素的个体可以帮助预防其对健康和医疗保健系统的影响。
{"title":"Loneliness as a determinant of health: evidence from the Health Survey of Catalonia.","authors":"Helena M Hernández-Pizarro, Albert Prades-Colomé, Guillem López-Casasnovas","doi":"10.1016/j.gaceta.2025.102491","DOIUrl":"10.1016/j.gaceta.2025.102491","url":null,"abstract":"<p><strong>Objective: </strong>This study investigates the health effects of loneliness among adults (18+ years) and elderly adults (60+ years).</p><p><strong>Method: </strong>Using data from the Health Survey of Catalonia (ESCA), 2013-2019, the effects of loneliness on health and healthcare utilization outcomes are estimated. Ordinary least squares estimates are provided to explore the channels affecting such relationships.</p><p><strong>Results: </strong>Loneliness is significantly associated to worse health outcomes in all age groups. Among adults, it reduces self-perceived health by 7.1%, increases multi-morbidities by 22.1%, and raises the probability of depression and anxiety by 65.8%. Consequently, a positive and strong association between suffering from loneliness and the use of healthcare resources is documented: with a 7.4% rise in medication use, 20.9% more emergency care visits, and 6.1% higher primary care use. Results for the elderly are aligned with adults, although the magnitude associated to self-perceived health is substantially greater (13.2%). Channels exploration identifies living alone (with a 97.3% increase) and poor household habitability (33.5% increase) as key predictors in all the analysis. Being foreign (60.3% increase in the adult population and 106% in the elderly population) and gender (women, 26.8% for the adult population and 27.5% in the elderly population) become relevant factors explaining loneliness.</p><p><strong>Conclusions: </strong>This study documents the impact of loneliness in Catalonia. Loneliness is associated to significant worse health and more use of healthcare. Tackling individuals with higher risk factors for loneliness could help preventing its concerning consequences on health and healthcare system.</p>","PeriodicalId":94017,"journal":{"name":"Gaceta sanitaria","volume":" ","pages":"102491"},"PeriodicalIF":1.5,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144340783","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Effectiveness and cost-effectiveness of non-pharmacological interventions for functional somatic disorders: systematic review of meta-analyses and economic evaluations]. [功能性躯体疾病的非药物干预的有效性和成本效益:荟萃分析和经济评估的系统回顾]。
IF 1.5 Pub Date : 2025-01-01 Epub Date: 2025-03-06 DOI: 10.1016/j.gaceta.2025.102457
Inmaculada Boluda-Verdú, Ferrán Catalá-López

Objective: To analyze the effectiveness and cost-effectiveness of non-pharmacological interventions for functional somatic disorders through a review of systematic reviews with meta-analysis and economic evaluations.

Method: Searches were carried out in PubMed/MEDLINE, EMBASE, Cochrane Database of Systematic Reviews and PsycINFO (until June 2024). Outcome measures were improvement in symptoms (for systematic reviews) and incremental cost-effectiveness ratio (for economic evaluations). Methodological quality was assessed with AMSTAR-2 for systematic reviews and with QHES for economic evaluations. A narrative synthesis of the studies was performed, without meta-analysis.

Protocol registration: Open Science Framework (https://osf.io/u3w2b/).

Results: 32 studies were included (27 systematic reviews and 5 economic evaluations). All systematic reviews included randomized trials, except 2 that also included non-randomized studies. In systematic reviews, the most studied conditions were gastrointestinal disorders (12/27) and physical symptoms not explained by an organic pathology (6/27), while in economic evaluations they were undifferentiated somatoform disorders (2/5). The systematic reviews that included comparisons of psychological therapies, mindfulness and herbal medicine seemed to indicate improvements in symptoms. However, those systematic reviews that included acupuncture were inconclusive. All economic evaluations were associated with randomized trials. The incremental cost-effectiveness ratios were dominant (less costs, more effective) in 2 studies evaluating cognitive behavioral therapy. Of the systematic reviews, 20 presented critically low quality, 5 low quality and 2 moderate quality, while the 5 economic evaluations presented high quality.

Conclusions: The evidence on the effectiveness and cost-effectiveness of non-pharmacological interventions for functional somatic disorders should be interpreted with caution since the majority of the systematic reviews were of low or critically low methodological quality, and with a high level of uncertainty in the case of economic evaluations. The diversity of definitions of the diagnosis and interventions makes it difficult to generalize these results.

目的:通过荟萃分析和经济评价的系统综述,分析非药物干预治疗功能性躯体疾病的有效性和成本效益。方法:检索PubMed/MEDLINE、EMBASE、Cochrane Database of Systematic Reviews和PsycINFO(截止至2024年6月)。结果指标为症状改善(用于系统评价)和增量成本-效果比(用于经济评价)。方法质量通过AMSTAR-2进行系统评价,QHES进行经济评价。对研究进行叙事综合,不进行meta分析。协议注册:开放科学框架(https://osf.io/u3w2b/)。结果:纳入32项研究(27项系统评价和5项经济评价)。除2项纳入非随机研究外,所有系统评价均纳入随机试验。在系统评价中,研究最多的疾病是胃肠道疾病(12/27)和不能用器质性病理解释的身体症状(6/27),而在经济学评价中,它们是未分化的躯体形式疾病(2/5)。包括心理疗法、正念和草药的比较在内的系统综述似乎表明症状有所改善。然而,那些包括针灸在内的系统评价是不确定的。所有经济评价均与随机试验相关。在2项评估认知行为疗法的研究中,增量成本-效果比占主导地位(成本更低,效果更佳)。系统评价中,极低质量评价20篇,低质量评价5篇,中等质量评价2篇,高质量评价5篇。结论:关于功能性躯体疾病的非药物干预的有效性和成本效益的证据应谨慎解释,因为大多数系统评价的方法学质量较低或极低,并且在经济评估的情况下具有很高的不确定性。诊断和干预定义的多样性使得很难概括这些结果。
{"title":"[Effectiveness and cost-effectiveness of non-pharmacological interventions for functional somatic disorders: systematic review of meta-analyses and economic evaluations].","authors":"Inmaculada Boluda-Verdú, Ferrán Catalá-López","doi":"10.1016/j.gaceta.2025.102457","DOIUrl":"10.1016/j.gaceta.2025.102457","url":null,"abstract":"<p><strong>Objective: </strong>To analyze the effectiveness and cost-effectiveness of non-pharmacological interventions for functional somatic disorders through a review of systematic reviews with meta-analysis and economic evaluations.</p><p><strong>Method: </strong>Searches were carried out in PubMed/MEDLINE, EMBASE, Cochrane Database of Systematic Reviews and PsycINFO (until June 2024). Outcome measures were improvement in symptoms (for systematic reviews) and incremental cost-effectiveness ratio (for economic evaluations). Methodological quality was assessed with AMSTAR-2 for systematic reviews and with QHES for economic evaluations. A narrative synthesis of the studies was performed, without meta-analysis.</p><p><strong>Protocol registration: </strong>Open Science Framework (https://osf.io/u3w2b/).</p><p><strong>Results: </strong>32 studies were included (27 systematic reviews and 5 economic evaluations). All systematic reviews included randomized trials, except 2 that also included non-randomized studies. In systematic reviews, the most studied conditions were gastrointestinal disorders (12/27) and physical symptoms not explained by an organic pathology (6/27), while in economic evaluations they were undifferentiated somatoform disorders (2/5). The systematic reviews that included comparisons of psychological therapies, mindfulness and herbal medicine seemed to indicate improvements in symptoms. However, those systematic reviews that included acupuncture were inconclusive. All economic evaluations were associated with randomized trials. The incremental cost-effectiveness ratios were dominant (less costs, more effective) in 2 studies evaluating cognitive behavioral therapy. Of the systematic reviews, 20 presented critically low quality, 5 low quality and 2 moderate quality, while the 5 economic evaluations presented high quality.</p><p><strong>Conclusions: </strong>The evidence on the effectiveness and cost-effectiveness of non-pharmacological interventions for functional somatic disorders should be interpreted with caution since the majority of the systematic reviews were of low or critically low methodological quality, and with a high level of uncertainty in the case of economic evaluations. The diversity of definitions of the diagnosis and interventions makes it difficult to generalize these results.</p>","PeriodicalId":94017,"journal":{"name":"Gaceta sanitaria","volume":" ","pages":"102457"},"PeriodicalIF":1.5,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143588959","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Comparative price analysis of healthcare interventions between autonomous communities]. [自治区卫生保健干预措施的价格比较分析]。
IF 1.5 Pub Date : 2025-01-01 Epub Date: 2025-04-23 DOI: 10.1016/j.gaceta.2025.102494
Luísa Serpa Dos Santos Gonçalves Ferreira, Rosa María Urbanos-Garrido

Objective: To highlight the differences in pricing applied to health interventions by the autonomous communities, as well as the heterogeneous definition of the basic list of services.

Method: A comparative analysis of the prices of representative procedures included in the common basket of health services was conducted, based on information from official publications of the autonomous communities.

Results: Significant prices variations for the same intervention were identified across autonomous communities, along with notable heterogeneity in service definitions.

Conclusions: The Interterritorial Council should promote transparency in the criteria used to set prices and enhance the coordination of regional health services in the definition, implementation, and development of analytical accounting systems. Additionally, it should standardize the specification of services included in the common basket of benefits to facilitate the analysis of regional differences in production costs.

目的:强调自治区卫生干预措施定价的差异,以及基本服务清单的异质定义。方法:根据自治区官方出版物的资料,对卫生服务共同篮子中代表性程序的价格进行比较分析。结果:在不同的自治社区中,相同干预措施的价格差异显著,服务定义也存在显著的异质性。结论:跨地区理事会应提高用于定价标准的透明度,并在分析会计系统的定义、实施和发展方面加强区域卫生服务的协调。此外,它还应使共同一揽子福利所包括服务的规格标准化,以便分析生产成本的区域差异。
{"title":"[Comparative price analysis of healthcare interventions between autonomous communities].","authors":"Luísa Serpa Dos Santos Gonçalves Ferreira, Rosa María Urbanos-Garrido","doi":"10.1016/j.gaceta.2025.102494","DOIUrl":"10.1016/j.gaceta.2025.102494","url":null,"abstract":"<p><strong>Objective: </strong>To highlight the differences in pricing applied to health interventions by the autonomous communities, as well as the heterogeneous definition of the basic list of services.</p><p><strong>Method: </strong>A comparative analysis of the prices of representative procedures included in the common basket of health services was conducted, based on information from official publications of the autonomous communities.</p><p><strong>Results: </strong>Significant prices variations for the same intervention were identified across autonomous communities, along with notable heterogeneity in service definitions.</p><p><strong>Conclusions: </strong>The Interterritorial Council should promote transparency in the criteria used to set prices and enhance the coordination of regional health services in the definition, implementation, and development of analytical accounting systems. Additionally, it should standardize the specification of services included in the common basket of benefits to facilitate the analysis of regional differences in production costs.</p>","PeriodicalId":94017,"journal":{"name":"Gaceta sanitaria","volume":" ","pages":"102494"},"PeriodicalIF":1.5,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144050377","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Gaceta sanitaria
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
﹀
mjeditor
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1